1CONNEELY O M,MULAC-JERICEVIC B,LYDON J P.Progesterone dependent regulation of female reproductive activity by two distinct progesterone receptor isoforms[J].Steroids,2003,68 (10-13):771-778.
2SITRUK-WARE R.Progestins in hormonal therapy (HT) today,tomorrow and the next day:a roundtable discussion[J].Steroid,2003,68(10-13):973-979.
3SITRUK-WARE R.Pharmocological profile of progestins[J].Maturitas,2004,47(4):277-283.
4DORING A,FROHLICH M,LOWEL H,et al.Third generation oral contraceptive use and cardiovascular risk factors[J].Atherosclerosis,2004,172(2):281-286.
5SITRUK-WARE R.New progestogens:a review of their effects in perimenopausal and postmenopausal women[J].Drugs Aging,2004,21(13):865-883.
6KLINGER G,PIATER T,JAEGER R,et al.Non-protein bound dienogest in serum and salivary dienogest in women taking the oral contraceptives Certostat and Valette[J].Pharmazie,2001,56(4):325-328.
7GEORGIEV D B,MANASSIEV N A.Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women[J].Medscape Womens Health,2002,7 (4):1.
8ROWLANDS S.Newer progestogens[J].J Fam Plann Reprod Health Care,2003,29(1):13-16.
9WIEGRATZ I,LEE J H,KUTSCHERA E,et al.Effect of dienogestcontaining oral contraceptives on lipid metabolism[J].Contraception,2002,65(3):223-229.
10GRASER T,ROMER T,WIEDEY K D,et al.Climodien (estradiol valerate 2 mg plus dienogest 2 mg) is safe and effective in the treatment of postmenopausal complaints[J].Climacteric,2001,4(4):332-342.
